BMY

Recent Articles

The 10 Best Pharma Stocks Under President Donald Trump

The world was shocked by Donald Trump's surprise victory, but few equities will benefit as much as big pharma stocks. More 

5 Healthcare Stocks Poised to Trump Q3 Earnings

Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat More 

3 Big Pharma Stocks That Are Looking a Little Pale

These Big Pharma stocks need to justify their big price tags after disappointing results: Bristol-Myers (BMY), Merck (MRK) and Eli Lilly (LLY). More 

BMY Stock: Don’t Try to Catch This Falling Knife … Yet

Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline. More 

Tuesday’s Vital Data: Apple Inc. (AAPL), Twitter Inc (TWTR) and Bristol-Myers Squibb Co (BMY)

A bid in Apple shares and strength from the energy complex put the NASDAQ back near all-time-highs, while TWTR and BMY are under pressure. More 

Why Twitter Inc (TWTR), Bristol-Myers Squibb Co (BMY) and Twilio Inc (TWLO) Are 3 of Today’s Worst Stocks

Twitter (TWTR), Bristol-Myers Squibb (BMY) and Twilio (TWLO) each uses more than their fair share of red ink on Monday. More 

Bristol-Myers Squibb Co (BMY) Suffers Heavy Dose of Disappointment

BMY stock -- at around $49 -- is now fairly valued. But given its failure rate, waiting for Bristol-Myers to get to "cheap" is the best bet before buying. More